Paul Janssen Contents Birth and education Career Death Popularity polls See also References Further...
1926 births2003 deathsBarons of BelgiumBelgian businesspeopleBelgian pharmacologistsBelgian Roman CatholicsBelgian scientistsBusinesspeople in the pharmaceutical industryFlemish peopleCatholic University of Leuven alumni (pre-1968)Ghent University alumniMembers of the Pontifical Academy of SciencesJanssen Pharmaceutica peoplePeople from TurnhoutAustralia Prize recipientsUniversité de Namur alumniBelgian inventors
TurnhoutRomeJanssen PharmaceuticaConstant JanssenJesuitFacultés universitaires Notre-Dame de la PaixNamurCatholic University of LeuvenUniversity of GhentUniversity of CologneCorneille HeymansNobel PrizefrancsambucetamideantispasmodicmenstrualhabilitationhaloperidolschizophreniafentanyldroperidoletomidateanesthesiologydiarrheaDiphenoxylateLomotilApollo programXi'anPaul LewisupercomputerJanssen PharmaceuticaWHO list of essential medicinesmental illnessescardiovascularallergiesgastrointestinal disordersPontifical Academy of Sciences
Paul Adriaan Jan, Baron Janssen (12 September 1926, Turnhout – 11 November 2003, Rome) was a Belgian doctor. He was the founder of Janssen Pharmaceutica, a pharmaceutical company with over 20,000 employees.[1]
Contents
1 Birth and education
2 Career
3 Death
4 Popularity polls
5 See also
6 References
7 Further reading
8 External links
Birth and education
Paul Janssen was the son of Constant Janssen and Margriet Fleerackers. On 16 April 1957, he married Dora Arts.
He attended secondary school at the Jesuit St Jozef college in Turnhout, after which he decided to follow in his father's footsteps and become a doctor. During World War II, Janssen studied physics, biology and chemistry at the Facultés universitaires Notre-Dame de la Paix (FUNDP) in Namur. He then studied medicine at the Catholic University of Leuven and the University of Ghent. In 1951, Janssen graduated in medicine from the University of Ghent.
Career
During his military service, he worked at the University of Cologne in Germany at the Institute of Pharmacology of J. Schuller, where he worked until 1952. After he returned to Belgium he worked part-time at the Institute of Pharmacology and Therapeutics (University of Ghent) of Professor Corneille Heymans, who had won the Nobel Prize for medicine in 1938. Janssen founded his own research laboratory in 1953, with a loan of 50,000 Belgian francs from his father. In 1953 he also discovered his first drug ambucetamide, an antispasmodic found to be particularly effective for the relief of menstrual pain.[2]
Statue of Dr. Paul Janssen in Beerse, Belgium
In 1956, Janssen received his teaching certificate for higher education in pharmacology (the habilitation and the official pro venia legendi (Latin, for permission to lecture)) with a thesis on Compounds of the R 79 type. He then left the university and in 1956 established the company which would become Janssen Pharmaceutica. On 11 February 1958 he made haloperidol a major breakthrough in the treatment of schizophrenia.[3] Paul Janssen and his team developed the fentanyl family of drugs, and many other anesthesia-related drugs, such as droperidol and etomidate which made a significant contribution to anesthesiology.[4][5] One of the drugs he developed for the treatment of diarrhea, Diphenoxylate (Lomotil) was used during the Apollo program.[6][7] In 1985, his company was the first Western pharmaceutical company to set up a pharmaceutical factory in the People's Republic of China (Xi'an).[8] In 1995 he founded the Center for Molecular Design, together with Paul Lewi, where he and his team[9] used a supercomputer to search for candidate molecules to find a treatment for AIDS.[10][11]
Janssen and the scientists at Janssen Pharmaceutica discovered more than 80 new medicines. Four of his medicines are on the WHO list of essential medicines; this is an absolute world record. The majority of the drugs he and his teams developed were for human medicine and are being used to treat infestations by fungi and worms, mental illnesses, cardiovascular diseases, allergies, and gastrointestinal disorders.
Death
Paul Janssen died in Rome, Italy, in 2003, while attending the celebration of the 400th anniversary of the founding of the Pontifical Academy of Sciences, of which he had been a member since 1990.[12] He was survived by his widow, Dora Arts Janssen, two sons, three daughters and 13 grandchildren.
Popularity polls
- In 2005 he finished as runner up, after Father Damien, in the poll for The Greatest Belgian organized by the regional Flemish television.[13]
- On Wednesday 22 October 2008, Paul Janssen was awarded the title of Most Important Belgian Scientist, an initiative of the Eos magazine.[14]
See also
- Gedeon Richter Ltd.
- Gairdner Foundation International Award
- Tibotec
- Rega Institute for Medical Research
References
^ Paul Lewi, Obituary of Dr Paul Janssen (1926–2003), Drug Discovery Today, Volume 9, Issue 10, 15 May 2004, Pages 432–433
^ I. Oransky, Paul Janssen, The Lancet, Volume 363, Issue 9404, Pages 251–251
^ B. Granger, S. Albu, The Haloperidol Story, Annals of Clinical Psychiatry (after 1 Jan 2004), Volume 17, Number 3, Number 3/July–September 2005, pp. 137–140(4)
^ Stanley TH, Egan TD, Van Aken H (2008). "A Tribute to Dr. Paul A. J. Janssen: Entrepreneur Extraordinaire, Innovative Scientist, and Significant Contributor to Anesthesiology" (PDF). Anesth Analg. 106 (2): 451–62. doi:10.1213/ane.0b013e3181605add. PMID 18227300. Retrieved 7 May 2011..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}
^ Lopez-Munoz, Francisco; Alamo, Cecilio (2009). "The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice". Brain Research Bulletin. 79: 130–141. doi:10.1016/j.brainresbull.2009.01.005. PMID 19186209.
^ "W. Royce Hawkins, M.D., John F. Zieglschmid, M.D., Clinical aspects of crew health". Lsda.jsc.nasa.gov. Archived from the original on 23 February 2012. Retrieved 12 March 2012.
^ "Apollo Medical Kits". History.nasa.gov. Retrieved 2012-03-12.
^ Magiels G, Paul Janssen. Pionier in farma en in China, Houtekiet, 2005
^ molmo.be Archived 31 July 2009 at the Wayback Machine
^ Yven Van Herrewege, Guido Vanham, Jo Michiels, Katrien Fransen, Luc Kestens, Koen Andries, Paul Janssen, and Paul Lewi, A Series of Diaryltriazines and Diarylpyrimidines Are Highly Potent Nonnucleoside Reverse Transcriptase Inhibitors with Possible Applications as Microbicides, Antimicrob Agents Chemother. 2004 October; 48(10): 3684–3689
^ "New AIDS Drug Discoveries To Battle Drug-Resistant HIV Strains". Sciencedaily.com. 2002-08-20. Retrieved 2012-03-12.
^ Neuropsychopharmacology. "Thomas A Ban, Paul Adriaan Jan Janssen, 1926–2003, Neuropsychopharmacology (2004) 29, 1579–1580". Nature.com. Retrieved 2012-03-12.
^ "De Grootste Belg". De Standaard (in Dutch). Retrieved 4 October 2011.
^ "Most Important Belgian Scientist". Picture.belga.be. 22 October 2008. Archived from the original on 20 February 2012. Retrieved 12 March 2012.
Further reading
- Lewi, Paul J., Successful Pharmaceutical Discovery: Paul Janssen's Concept of Drug Research, R&D Management, Vol. 37, Issue 4, pp. 355–362, September 2007.
- van Gestel S, Schuermans V, Thirty-three years of drug discovery and research with Dr. Paul Janssen, Drug Development Research, Volume 8, Issue 1–4, pp. 1–13.
Geerdt Magiels; Joos Horsten (2004). Paul Janssen: pionier in farma en in China. Houtekiet. ISBN 9789052408279.
- Drug Design with Dr. Paul Janssen
- In memory of Dr. Paul Janssen
- Rory Watson, Paul Janssen, BMJ 2003;327;1290
- 1996 Australia Prize
External links
- Dr Paul Janssen
- Paul Adriaan Jan Janssen, 1926–2003
Paul Janssen (Obituary)- Dr. Paul Janssen Award for Biomedical Research
Authority control  |
|
|---|
